Biotechnology Services Global Market Report 2026

Biotechnology services involve the modification of living microorganisms to produce customized biotechnology products for medical, pharmaceutical, and scientific laboratories on a contract or custom basis. These services contribute to the development of breakthrough products and technologies aimed at addressing diseases, environmental concerns, hunger, energy efficiency, and cleaner industrial processes.

Key types of biotechnology services include prevention and disease control, public engagement activities, health education and research, food biotechnology services, donor recruitment, tissue collection, cell processing and isolation, and research and development. Food biotechnology services cover various technologies applied in crops, livestock, forestry, fisheries, aquaculture, and agro-industry. These services are utilized for genetic improvement, conservation of genetic resources, disease diagnosis, vaccine development, and fermented food production. Applications of biotechnology services span the pharmaceutical, biotechnological, academic, clinical trial, and healthcare sectors, with usage by Clinical Research Organizations (CROs), Contract Manufacturers Organizations (CMOs), and Contract Research and Manufacturing Services (CRAMS).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the biotechnology services market by increasing costs of imported laboratory equipment, reagents, bioprocessing instruments, and specialized consumables used across research, cell processing, and development services. Research institutions and contract service providers in North America and Europe are most affected due to reliance on imported high-value scientific equipment, while Asia-Pacific faces cost pressure on service exports. These tariffs are raising operational expenses and project costs. However, they are also encouraging localized manufacturing of lab equipment, regional supplier diversification, and increased domestic investment in biotechnology infrastructure.

The biotechnology services market research report is one of a series of new reports from The Business Research Company that provides biotechnology services market statistics, including biotechnology services industry global market size, regional shares, competitors with a biotechnology services market share, detailed biotechnology services market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology services industry. This biotechnology services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biotechnology services market size has grown rapidly in recent years. It will grow from $178.54 billion in 2025 to $196.54 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to expansion of pharmaceutical R&D activities, rising prevalence of chronic and rare diseases, growth of contract research organizations, increasing public and private research funding, advancements in molecular biology techniques.

The biotechnology services market size is expected to see rapid growth in the next few years. It will grow to $314.12 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to increasing adoption of precision medicine, rising investments in genomics research, expansion of cell and gene therapy pipelines, growing demand for scalable biotechnology services, increasing integration of ai in life science research. Major trends in the forecast period include increasing outsourcing of drug discovery services, rising demand for cell processing and isolation services, growing adoption of contract research models, expansion of personalized medicine support services, enhanced focus on translational research capabilities.

The growing prevalence of conditions such as hepatitis B, diabetes, and cancer is fueling biotechnology research. Biotechnology utilizes research tools from biology and chemistry to examine the genetic material of bacteria and viruses to identify disease-causing agents. Among biopharma companies, oncology research stands out as the most significant focus. Advances in medical applications include stem cell treatments utilizing monoclonal antibodies and genome sequencing. For example, in June 2024, the National Health Service (NHS), a UK-based government department, reported that in 2023, it identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, raising the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a general practitioner (GP) to 3,615,330. This marks a notable increase from 3,065,825 in 2022, reflecting a rise of nearly 20%. Additionally, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, projected that by 2050, there would be over 35 million new cancer cases, representing a 77% increase compared to an estimated 20 million cases in 2022. Consequently, the rising prevalence of diseases and significant investments in R&D are expected to drive growth in the biotechnology services market.

Key companies within the biotechnology services market are dedicated to pioneering innovative therapies, such as biomarker algorithms for the primary treatment of patients with non-small cell lung cancer (NSCLC). Biomarker algorithms encompass mathematical or computational models integrating data from multiple biological indicators to provide comprehensive assessments of specific medical conditions. For instance, in April 2023, Strata Oncology Inc., a US-based precision oncology company, introduced Strata Select-a groundbreaking molecular profiling test for advanced cancer patients. Noteworthy for being the first immunotherapy biomarker algorithm covered by Medicare across solid tumors, Strata Select empowers oncologists to make more informed treatment decisions, thereby enhancing patient outcomes.

In December 2023, Eli Lilly and Company, a US-based pharmaceutical firm, acquired POINT Biopharma Global Inc. for an undisclosed sum. This strategic acquisition aims to enhance Lilly's oncology expertise, particularly in advanced radioligand therapies designed to treat various forms of cancer. POINT Biopharma Global Inc. is a US-based biotechnology company recognized for its innovative methods in cancer treatment.

Major companies operating in the biotechnology services market include Parexel International Corporation, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, IQVIA, ICON plc, Charles River Laboratories, Syneos Health, Sartorius AG, Precision for Medicine Inc., Novartis, Eppendorf Asia Pacific Sdn. Bhd., Emmessar Biotech & Nutrition LTD, Vcanbio Cell & Gene Engineering Corp., LTD, Ke Rui Gene, Absea Biotechnology LTD, CStone Pharm-B, Daiichi Sankyo, bitBiome, Taisho Pharmaceutical, AGC Biologics, Hamamatsu Pharma Research, Artios Pharma, AstraZeneca, Bio Products Laboratory (BPL), Cambridge Bioscience, Shire Pharmaceuticals LTD, BTG LTD, eXmoor Pharma, 4D Pharma PLC, Touchlight Genetics, Ophidia Medical Technologies, ATAI Life Sciences, Phaseform, Evotec, Sanity Group, Primmbiotech Vaccitech, Biolat, Asla-Biotech, Genera, Anima Lab, Silvanols, OU TBD-Biodiscovery, Qvalitas Arstikeskus AS, Concise Systems OU, GPE Globalpharma OU, Belarusian National Biotechnology Corporation, Innothera, Olainfarm, Pharmaidea, Amgen Inc., Gilead Sciences, Celgene Corporation, Biogen Inc., Vertex Pharmaceuticals, Illumina, Inc., Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals, Hemostemix Inc., Resverlogix Corporation, Zenith Epigenetics Corp., Bayer, AMEGA Biotech, Pierre Fabre, Pfizer, Quantificare, Apsen Farmaceutica, BioMarin Pharmaceutical, DK Diagnostics, Biosonda Biotechnology, Laboratorios Legrand, Biomerics, Julphar Pharmaceuticals, Medpharma, Pharmax, Neopharma, City Breeze Technical Services, CinnaGen, BioSun Pharmed, AryoGen Pharmed, 4Clinics, 54gene, Amoun, Aspen Pharmacare, BBI Solutions, BioTech Africa, ClinArt MENA, Crux Pharmaceuticals, Genesis Pharmaceuticals, Massive Genomics, Mayne Pharma, Sanofi Genzyme, Teleflex Medical, The Micron Group

Asia-Pacific was the largest region in the biotechnology services market in 2025. North America was the second largest region in the global biotechnology services market analysis. The regions covered in the biotechnology services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biotechnology services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biotechnology services market consists of revenue earned by entities that engage in conducting research and experimental development in biotechnology. Numerous global issues are helped by biotechnology, including infectious diseases, ageing societies, food security, energy security, and climate change, to name a few. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biotechnology Services Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biotechnology services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biotechnology services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biotechnology services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Service: Research & Development Services; Cell & Gene Processing Services; Preclinical & Clinical Research Services; Analytical & Testing Services
• 2) By Service Delivery Model: Contract Research Organization (CRO) Services; Contract Development and Manufacturing Organization (CDMO) Services; Contract Research and Manufacturing Services (CRAMS)
• 3) By Area of Application: Pharmaceutical; Biotechnology; Clinical Trials; Research & Development Services
• Subsegments:
• 1) Research & Development Services: Drug Discovery & Target Identification; Assay Development & Screening Services; Biomarker Discovery & Validation
• 2) Cell & Gene Processing Services: Stem Cell Processing & Expansion; Immune Cell Isolation & Engineering; Gene Editing & Vector Development
• 3) Preclinical & Clinical Research Services: In-Vitro & In-Vivo Preclinical Studies; Clinical Trial Design & Management; Bioanalytical & Pharmacokinetic Studies
• 4) Analytical & Testing Services: Genomic & Proteomic Testing; Bioanalytical Testing; Quality Control & Validation Testing
• Companies Mentioned: Parexel International Corporation; IQVIA; ICON PLC; Charles River Laboratories; Syneos Health; Thermo Fisher Scientific; Laboratory Corporation of America Holdings; Sartorius AG; Precision for Medicine Inc.; AGC Biologics; Evotec; Lonza Group; Catalent Inc.; WuXi AppTec; Samsung Biologics; BioReliance Corporation; Pharmaron; Recipharm AB; Abzena; Touchlight Genetics; Vcanbio Cell & Gene Engineering Corp LTD; 54gene
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.